论文部分内容阅读
恶性肿瘤并发的弥漫性血管内凝血(DIC)是由于肿瘤细胞释放出凝血激酶类物质和肿物增殖所造成的组织损伤以及血管内皮细胞功能障碍等因素所致。恶性肿瘤患者的DIC并发率较高,是在癌患机体内凝血纤溶系统处于比较局限和较轻的功能调节紊乱状态下发生的。易并发DIC的恶性肿瘤应首举白血病,也有报告指出,各种实质性癌的DIC并发率为4～10%。而有关女性生殖器恶性肿瘤并发DIC报道甚少。作者根据36例原发性卵巢癌并发DIC情况进行了观察与分析。 1.DIC并发率:36例肿瘤患者均进行了手术和术后化疗,有14例DIC,占38.9%。根据肿瘤病理分型来看,18例浆液性囊腺癌中并发9例DIC,占
Malignant tumor complicated by diffuse intravascular coagulation (DIC) is due to tumor cells release of thromboplastin and tissue proliferation caused by tissue damage and vascular endothelial dysfunction and other factors. Patients with malignant tumors have a high rate of concurrent DIC, which occurs when the coagulation-fibrinolytic system is in a more confined and less dysfunctional state of the regulatory function in cancer patients. Easy to concurrent malignant tumors of DIC should be the first to leukemia, there are also reports that a variety of substantial cancer DIC concurrent rate of 4 to 10%. However, there are few reports on the concomitant DIC in female genital malignancies. The author based on 36 cases of primary ovarian cancer complicated with DIC were observed and analyzed. 1.DIC concurrent rate: 36 cases of patients with tumor surgery and postoperative chemotherapy, 14 cases of DIC, accounting for 38.9%. According to the classification of tumor pathology, 18 cases of serous cystadenocarcinoma in 9 cases of DIC, accounting for